232 related articles for article (PubMed ID: 30272295)
1. Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells.
Ko YS; Jin H; Lee JS; Park SW; Chang KC; Kang KM; Jeong BK; Kim HJ
Oncol Rep; 2018 Dec; 40(6):3752-3762. PubMed ID: 30272295
[TBL] [Abstract][Full Text] [Related]
2. P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.
Jin H; Ko YS; Kim HJ
Int J Oncol; 2018 Nov; 53(5):1953-1966. PubMed ID: 30226596
[TBL] [Abstract][Full Text] [Related]
3. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
4. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.
Gonçalves Ndo N; Colombo J; Lopes JR; Gelaleti GB; Moschetta MG; Sonehara NM; Hellmén E; Zanon Cde F; Oliani SM; Zuccari DA
PLoS One; 2016; 11(3):e0150407. PubMed ID: 26934679
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of GSK3 and MEK induced cancer stem cell generation via the Wnt and MEK signaling pathways.
Liao S; Gan L; Qin W; Liu C; Mei Z
Oncol Rep; 2018 Oct; 40(4):2005-2013. PubMed ID: 30066938
[TBL] [Abstract][Full Text] [Related]
6. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
[TBL] [Abstract][Full Text] [Related]
7. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
[TBL] [Abstract][Full Text] [Related]
8. Radio resistance in breast cancer cells is mediated through TGF-β signalling, hybrid epithelial-mesenchymal phenotype and cancer stem cells.
Yadav P; Shankar BS
Biomed Pharmacother; 2019 Mar; 111():119-130. PubMed ID: 30579251
[TBL] [Abstract][Full Text] [Related]
9. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.
Knezevic J; Pfefferle AD; Petrovic I; Greene SB; Perou CM; Rosen JM
Oncogene; 2015 Dec; 34(49):5997-6006. PubMed ID: 25746005
[TBL] [Abstract][Full Text] [Related]
10. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
[TBL] [Abstract][Full Text] [Related]
11. Curcumin attenuates lncRNA H19‑induced epithelial‑mesenchymal transition in tamoxifen‑resistant breast cancer cells.
Cai J; Sun H; Zheng B; Xie M; Xu C; Zhang G; Huang X; Zhuang J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179087
[TBL] [Abstract][Full Text] [Related]
12. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.
Zhang L; Xu L; Zhang F; Vlashi E
Cell Cycle; 2017 Apr; 16(8):737-745. PubMed ID: 27753527
[TBL] [Abstract][Full Text] [Related]
13. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen-resistant breast cancer cells possess cancer stem-like cell properties.
Liu H; Zhang HW; Sun XF; Guo XH; He YN; Cui SD; Fan QX
Chin Med J (Engl); 2013 Aug; 126(16):3030-4. PubMed ID: 23981606
[TBL] [Abstract][Full Text] [Related]
15. Identification of new cancer stem cell markers and signaling pathways in HER‑2‑positive breast cancer by transcriptome sequencing.
Feng L; Huang S; An G; Wang G; Gu S; Zhao X
Int J Oncol; 2019 Nov; 55(5):1003-1018. PubMed ID: 31545416
[TBL] [Abstract][Full Text] [Related]
16. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
18. Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways.
Cao L; Yang Y; Ye Z; Lin B; Zeng J; Li C; Liang T; Zhou K; Li J
Int J Mol Med; 2018 Sep; 42(3):1625-1636. PubMed ID: 29956731
[TBL] [Abstract][Full Text] [Related]
19. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
20. miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.
Fu H; Fu L; Xie C; Zuo WS; Liu YS; Zheng MZ; Yu JM
Oncol Rep; 2017 Feb; 37(2):1093-1099. PubMed ID: 28075453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
